Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

Who May Qualify: - Aged between 16 years and 40 years (inclusive) - Viable singleton pregnancy with gestational age estimated less than 13 6/7 weeks (inclusive) by ultrasound - HIV-uninfected - Willing to participate in the study schedule - Planning to remain in the study area for the duration of pregnancy and 1 month after delivery - Willing to deliver in a study-affiliated health facility Who Should NOT Join This Trial: - High risk pregnancy that requires referral for specialized care by local guidelines - Active medical problem at the time of screening requiring higher level care - Antimalarial receipt in the 2 weeks prior to screening - Past allergy to Artemether or Lumefantrine or another condition that prohibits the receipt of either drug - Current participation in another clinical research study Always talk to your doctor about whether this trial is right for you.